Financing - May 5, 2026
IRLAB resolves on a rights issue of approx SEK 68 million
The Board of Directors of IRLAB Therapeutics has resolved on a rights issue of shares of series A corresponding to approximately SEK 68 million.
Biotech Business - April 16, 2026
EIB backs BioLamina with EUR 20 million
The European Investment Bank (EIB) is lending EUR 20 million to BioLamina to expand its development of laminin technologies.
Financing - April 10, 2026
Isofol receives gross proceeds of SEK 18.9 million
The exercise period for warrants of series TO1 in Isofol ended on 30 March 2026 and the outcome shows that a total of 37,301,067 TO1 were exercised for subscription of 37,301,067 new shares, corresponding to a subscription rate of approximately 93.57 per cent.
Biotech Business - March 25, 2026
Tenboron receives EUR 7.6 million EU funding
Tenboron has received a positive funding decision from the European Union Horizon Europe Health 2025 programme for Phase 1 and 2 clinical studies of its TB0010 boron carrier for Boron Neutron Capture Therapy (BNCT).
Financing - March 25, 2026
ProteomEdge raises SEK 8 million
The company has announced the completion of a second funding round, led by Navigare Ventures, a subsidiary of Wallenberg Investments, with continued strong participation from existing shareholders.
Financing - February 24, 2026
Oncopeptides carries out a rights issue of approx SEK 200 million
The Board of Directors has resolved to carry out a new share issue of approximately SEK 200 million with preferential rights for the company’s existing shareholders based on the authorization granted by the Annual General Meeting on 22 May 2025.
